For research use only. Not for use in humans.

Atinumab (Anti-RTN4 / NOGO)

Synonyms: 6A3-IgG4, ATI355 Cat.No.A3051 Purity:99%

Atinumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI). MW :137.82 KD.

Quality Control

Batch: A305101 Purity: 99% Protein concentration: 7.378mg/ml Endotoxin Level: ＜1EU/mg

Cited in Nature Medicine for its top-tier quality
COA
SDS
Datasheet

Mechanism of Action

Description	Atinumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI). MW :137.82 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/29869587/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1226761-65-4
Isotype	Human IgG4SP
Source	CHO
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.